Drug-Induced QT Prolongation: Individual Susceptibility and Regulatory Issues Related to Safety Pharmacology 2. Evaluation of QT Interval Prolongation in Non-Clinical Studies According to ICH S7A and S7B and Its Questions at Issue

Japanese Journal of Clinical Pharmacology and Therapeutics - Japan
doi 10.3999/jscpt.37.4_201
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Japanese Society of Clinical Pharmacology and Therapeutics

Related search

QT Interval Prolongation Due to Metronidazole Administration

Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology
2011English

Prediction of Drug-Induced QT Interval Prolongation in Telemetered Common Marmosets

Journal of Toxicological Sciences
MedicineToxicology
2008English

Ever-Expanding Clinical Implications of QT Interval Prolongation

Future Cardiology
Molecular MedicineCardiovascular MedicineCardiology
2015English

Predicting Drug-Induced QT Prolongation and Torsades De Pointes

Journal of Physiology
PhysiologySports Science
2016English

Translating QT Interval Prolongation From Conscious Dogs to Humans

British Journal of Clinical Pharmacology
Pharmacology
2016English

QT Interval Prolongation and Torsades De Pointes With Oxaliplatin

Therapeutic Advances in Drug Safety
Pharmacology
2016English

Brugada Syndrome and QT Prolongation Syndrome

THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA
2012English

Drug-Induced QT Prolongation in Women During the Menstrual Cycle

JAMA - Journal of the American Medical Association
Medicine
2001English

Towards Limiting QT Interval Prolongation and Arrhythmia Risk in Citalopram Use

Cardiology Journal
MedicineCardiovascular MedicineCardiology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy